Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | PRKCA | P17252 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23996054 | 0.78 | POLB (0.33) | POLBGAANPSR1PRKCA | |
| SCHEMBL19865688 | 0.76 | POLB (0.36) | POLBGAANPSR1PRKCA | |
| SCHEMBL8962465 | 0.76 | PRKCA (0.41) | POLBGAANPSR1PRKCA | |
| SCHEMBL13073713 | 0.75 | POLB (0.40) | POLBGAANPSR1PRKCA | |
| SCHEMBL1753756 | 0.72 | POLB (0.43) | POLBGAANPSR1PRKCA | |
| SCHEMBL9925701 | 0.72 | GAA (0.43) | POLBGAANPSR1PRKCA | |
| SCHEMBL22856131 | 0.71 | PRKCA (0.33) | POLBGAANPSR1PRKCA | |
| SCHEMBL22855965 | 0.71 | PRKCA (0.37) | POLBGAANPSR1PRKCA | |
| SCHEMBL4258156 | 0.71 | POLB (0.48) | POLBGAANPSR1PRKCA | |
| SCHEMBL22855964 | 0.70 | PRKCA (0.33) | POLBGAANPSR1PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200369703-A1 | Modified oligonucleotides and compound that can be used for synthesizing same | GUANGZHOU RIBOBIO CO LTD (CN) | 2020-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200369703-A1 | Modified oligonucleotides and compound that can be used for synthesizing same | POLRMT, RNASE1, ADAR | POLB 82/4885GAA 380/4885NPSR1 2569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.